During the past decade, Shoklo Malaria Research Unit conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shoklo Malaria Research Unit" #1 collaborator was "Shoklo Malaria Research Unit" with 7 trials as a collaborator, "Mahidol Oxford Tropical Medicine Research Unit" with 6 trials as a collaborator, "Mahidol University" with 5 trials as a collaborator, "Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit" with 3 trials as a collaborator and "Building Resources Across Communities (BRAC), Bangladesh" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Shoklo Malaria Research Unit" are "Malaria" (7 trials), "Vivax Malaria" (5 trials), "Malaria, Vivax" (2 trials), "P. Falciparum Malaria" (2 trials) and "Plasmodium Falciparum Malaria" (2 trials). Many other conditions were trialed in "Shoklo Malaria Research Unit" in a lesser frequency.

Most popular intervention types in "Shoklo Malaria Research Unit" are "Drug" (16 trials), "Other" (4 trials), "Diagnostic Test" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chloroquine" (3 trials), "Primaquine" (3 trials), "Dihydroartemisinin-Piperaquine" (2 trials), "Antimalarials" (1 trials) and "Artesunate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shoklo Malaria Research Unit" are 37 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are 8 active trials in "Shoklo Malaria Research Unit". 2 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in Shoklo Malaria Research Unit, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Shoklo Malaria Research Unit, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".